Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Lactobacillus reuteri DSM 17938 and Reduced Adiposity

Doses used in studies

CFU/day: 100 million–10 billion (median 5.0 billion, IQR 100 million–10 billion) — 1 study

Time to effect

Median: 2.8 months · IQR 2.8 months–2.8 months · Range 2.8 months–2.8 months — Reported in 1 of 1 study

1 of 1 paper

Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial.
- 2017-02-07
- RCT · n = 46
- Diabetes, obesity & metabolism 19(4)
- - Reza Mobini
  - Valentina Tremaroli
  - Marcus Ståhlman
  - Fredrik Karlsson
  - Max Levin
  - Maria Ljungberg
  - Maja Sohlin
  - Heléne Bertéus Forslund
  - Rosie Perkins
  - Fredrik Bäckhed
  - Per-Anders Jansson
- PubMed: 28009106
- DOI: 10.1111/dom.12861
5 Insights on
- Reduced Adiposity
- High evidence
- Highly Cited
- Clinical
Supplementation with L. reuteri DSM 17938 for 12 weeks did not affect ... adiposity
Effect
Neutral
Effect size
Small
Significant
No
Dose
10^8 CFU/d or 10^10 CFU/d